What is Cepirome & Sulbactam Injection 1.5 Gm.?

Cepirome & Sulbactam Injection 1.5 Gm. is supplied as a dry powder injection in a vial and is described as a cephalosporin combination product. Sulbactam is a beta-lactamase inhibitor used in certain antibiotic combinations. The identity of the other active ingredient, the exact composition, approved indications and administration instructions must be verified from the product-specific documentation before clinical claims are finalised.

Uses / Indications

If the intended active ingredient is confirmed as cefpirome combined with sulbactam, the product may be considered for selected bacterial infections where this combination is appropriate and the causative organisms are susceptible.

Cefpirome is a fourth-generation cephalosporin, while sulbactam inhibits certain beta-lactamase enzymes. However, the approved indications for this specific product must be verified before publication.

• Use only for bacterial infections covered by the approved product information.

• Consider microbiological susceptibility results where available.

• Do not use antibiotics to treat viral infections such as influenza or the common cold.

6. Benefits

Subject to confirmation of the composition, potential product characteristics include:

• Combination of a cephalosporin antibacterial agent and a beta-lactamase inhibitor.

• Dry powder injection presentation for professional preparation and administration.

• Potential use in appropriate clinical settings when supported by susceptibility data and prescribing guidance.

• Vial-based presentation for institutional pharmaceutical supply.

These characteristics do not guarantee clinical outcomes or establish superiority over other antibiotics.

7. Side Effects

The following risks require confirmation against the approved information for the actual combination.

Common Side Effects

Potential effects associated with cephalosporin antibiotics may include:

• Diarrhoea or other gastrointestinal disturbances.

• Skin rash.

• Injection-site discomfort or inflammation.

• Changes in liver enzyme results.

Less Common or Serious Side Effects

• Serious allergic reactions, including anaphylaxis.

• Severe or persistent antibiotic-associated diarrhoea.

• Blood cell abnormalities.

• Kidney-related adverse effects or neurological reactions where relevant to the active ingredients and patient risk factors.

The precise side-effect profile and incidence cannot be established reliably until the composition is confirmed. Suspected serious reactions require prompt medical assessment.

8. How Does It Work?

If the product contains cefpirome and sulbactam, the two components have complementary roles:

• Cefpirome: A beta-lactam antibiotic that interferes with bacterial cell-wall synthesis by binding to penicillin-binding proteins.

• Sulbactam: A beta-lactamase inhibitor that can protect susceptible partner antibiotics from certain bacterial enzymes that would otherwise inactivate them.

The combination’s overall activity depends on the bacterial species, resistance mechanisms and susceptibility of the organism. It is not effective against viral infections.

9. Dosage Guidelines

Dosage must be determined by a qualified healthcare professional after confirming the exact composition and approved product information.

Factors affecting dosage include:

• Type and severity of infection.

• Susceptibility of the causative organism.

• Patient age, weight and clinical condition.

• Renal function and any necessary dose adjustment.

• Confirmed strength and prescribed administration route.

The supplied strength is 1.5 Gm. The individual quantities of each active ingredient have not been provided and must not be inferred from the total strength alone.

Dry powder injections must be prepared and administered by qualified healthcare professionals according to the approved product-specific instructions. Do not assume a diluent, reconstitution volume, injection route or administration rate.

The exact dose and treatment duration should follow the approved product information and the recommendation of a qualified healthcare professional.

10. When Not to Use

Do not use the product in a patient with a known contraindicating hypersensitivity to any confirmed active ingredient or other component, as specified in the approved product information.

Before administration:

• Review previous allergic reactions to cephalosporins and other beta-lactam antibiotics.

• Assess any history of severe drug hypersensitivity.

• Confirm suitability in patients with significant renal impairment or other relevant clinical conditions.

• Follow the product-specific contraindications and precautions.

A penicillin allergy does not automatically mean that every cephalosporin is absolutely contraindicated. The nature and severity of the previous reaction require professional assessment.

11. Drug / Product Interactions

Interactions must be checked against the confirmed composition and prescribing information. Depending on the actual active ingredients, healthcare professionals may need to assess:

• Other medicines that can affect kidney function.

• Anticoagulants and medicines requiring coagulation monitoring.

• Other antibiotics or medicines with documented interactions.

• Potential laboratory test interference specified in the product information.

These are considerations for professional review, not confirmed interactions for this specific product. Medicines should not be mixed in the same syringe, infusion or administration line unless compatibility is verified.

12. Safety Advice

• Use only under appropriate medical supervision.

• Confirm the active ingredients and strength before administration.

• Review the patient’s allergy history.

• Assess renal function when clinically indicated.

• Follow the approved preparation, compatibility and administration instructions.

• Monitor for significant adverse reactions.

• Use antibiotics only for appropriate bacterial indications to support antimicrobial stewardship.

• Assess pregnancy, breastfeeding and paediatric use against the confirmed product information.

13. General Instructions

• Check the product name, strength, batch number and expiry date.

• Inspect the vial and container closure for damage.

• Follow the approved instructions for reconstitution and administration.

• Use appropriate aseptic handling procedures.

• Do not use products that fail applicable quality checks.

• Follow the documented conditions and time limits for use after reconstitution.

• Dispose of unused medicine and clinical waste in accordance with applicable procedures.

Do not apply preparation instructions from a different cephalosporin combination to this product.

14. Special Dietary / Lifestyle Tips

No universal dietary restriction can be established for this injectable combination without confirming its composition and product information.

• Follow the prescribed treatment plan.

• Complete the course as directed by the treating healthcare professional.

• Do not share antibiotics or use leftover medicines.

• Report persistent diarrhoea, rash or other significant adverse symptoms promptly.

• Follow any additional dietary or lifestyle advice provided for the underlying infection or medical condition.

15. Comparison with Other Treatments

If cefpirome is confirmed, the product may be compared clinically with other cephalosporin combinations, but its suitability depends on the specific infection and resistance profile. It should not be assumed to be more effective or safer than cefepime, cefoperazone combinations or other antibiotics.

Antibiotic selection should be based on clinical assessment, microbiological findings where available and applicable treatment guidelines.

16. Precautions & Warnings

• Allergy risk: Check for hypersensitivity to the confirmed active ingredients and relevant antibiotic classes.

• Renal impairment: Assess kidney function and follow any product-specific dose adjustment requirements.

• Gastrointestinal complications: Evaluate severe or persistent diarrhoea during or after antibiotic treatment.

• Blood and liver effects: Monitor as directed by the approved prescribing information.

• Antimicrobial resistance: Avoid unnecessary antibiotic use and follow appropriate prescribing guidance.

• Special populations: Pregnancy, breastfeeding, paediatric use and treatment in older adults require assessment against the confirmed product information.

These precautions must be finalised against the actual approved product label before publication.

17. Can I Use It With Other Medicines?

Concurrent use depends on the confirmed active ingredients, the patient’s clinical condition and the other medicines being taken.

Inform the treating healthcare professional about all prescription medicines, non-prescription medicines and supplements.

Drug interactions and physical compatibility are different: medicines must not be mixed in the same syringe, infusion or administration line without verified compatibility information.

18. Storage

Store according to the manufacturer’s approved product labelling. Refer to the product packaging or package insert for the applicable storage conditions.

Storage temperature, protection from light, shelf life and conditions after reconstitution must be confirmed from the product-specific documentation.

19. Frequently Asked Questions (FAQs)

1. What is Cepirome & Sulbactam Injection 1.5 Gm. used for?

It is listed as a cephalosporin combination dry powder injection. Its exact clinical indications must be confirmed from the approved product information.

2. Which active ingredients does this product contain?

The supplied product name identifies “Cepirome” and sulbactam. The precise generic name and active ingredient composition require verification against the product label.

3. What does the 1.5 Gm. strength mean?

It indicates the stated total product strength. The quantities of the individual active ingredients should be confirmed from the approved specification.

4. How is this injection prepared?

A qualified healthcare professional must prepare it according to the approved product-specific instructions. No universal diluent or reconstitution volume should be assumed.

5. Can it be used in patients with a penicillin allergy?

An allergy history requires professional assessment. The decision depends on the confirmed ingredients, the nature of the previous reaction and the applicable prescribing information.

6. What precautions are required before administration?

Confirm the composition, strength, allergy history, prescribed route and relevant patient factors. Follow the product-specific instructions.

7. How should the injection be stored?

Follow the manufacturer’s approved storage instructions. The required temperature and post-reconstitution conditions must be verified.

8. Is the product available for pharmaceutical export?

Kelar Pharmachem India is a pharmaceutical sourcing and export company. Product availability, export documentation, packaging and destination-market requirements can be confirmed through a product-specific enquiry.